Abstract:The demonstration of metabolically active brown adipose tissue (BAT) in humans primarily using positron emission tomography coupled to computed tomography (PET/CT) with the glucose tracer 18-fluorodeoxyglucose (18FDG) has renewed the interest of the scientific and medical community in the possible role of BAT as a target for the prevention and treatment of obesity and type 2 diabetes (T2D). Here, we offer a comprehensive review of BAT energy metabolism in humans. Considerable advances in methods to measure BAT energy metabolism, including nonesterified fatty acids (NEFA), chylomicron-triglycerides (TG), oxygen, Krebs cycle rate, and intracellular TG have led to very good quantification of energy substrate metabolism per volume of active BAT in vivo. These studies have also shown that intracellular TG are likely the primary energy source of BAT upon activation by cold. Current estimates of BAT's contribution to energy expenditure range at the lower end of what would be potentially clinically relevant if chronically sustained. Yet, 18FDG PET/CT remains the gold-standard defining method to quantify total BAT volume of activity, used to calculate BAT's total energy expenditure. Unfortunately, BAT glucose metabolism better reflects BAT's insulin sensitivity and blood flow. It is now clear that most glucose taken up by BAT does not fuel mitochondrial oxidative metabolism and that BAT glucose uptake can therefore be disconnected from thermogenesis. Furthermore, BAT thermogenesis is efficiently recruited upon repeated cold exposure, doubling to tripling its total oxidative capacity, with reciprocal reduction of muscle thermogenesis. Recent data suggest that total BAT volume may be much larger than the typically observed 50-150 ml with 18FDG PET/CT. Therefore, the current estimates of total BAT thermogenesis, largely relying on total BAT volume using 18FDG PET/CT, may underestimate the true contribution of BAT to total energy expenditure. Quantification of the contribution of BAT to energy expenditure begs for the development of more integrated whole body in vivo methods.

Secretory Role of Brown Adipose Tissue

The Adipokines of Brown Fat

Energy metabolism in brown adipose tissue

Brown adipose tissue as a secretory organ

The Brown Fat Secretome: Metabolic Functions Beyond Thermogenesis

Brown Adipose Tissue Heterogeneity, Energy Metabolism, and Beyond

Brown Adipose Tissue: Activation and Metabolism in Humans

The Role of Brown Adipose Tissue Dysfunction in the Development of Cardiovascular Disease

Brown Adipose Tissue and Its Role in Insulin and Glucose Homeostasis

Brown Fat as a Regulator of Systemic Metabolism beyond Thermogenesis

Brown Adipose Tissue—A Translational Perspective

[Brown Adipose Tissue in Human and Its Potential Physiological Significance].

Factors Associated with White Fat Browning: New Regulators of Lipid Metabolism

The Role and Regulatory Mechanism of Brown Adipose Tissue Activation in Diet-Induced Thermogenesis in Health and Diseases

Research advances in brown adipose tissue biology

The Heartwarming Effect of Brown Adipose Tissue

Nutritional Regulation of Human Brown Adipose Tissue

Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia

Brown and Beige Fat： the Metabolic Function, Induction, and Therapeutic Potential

Regulation Factors Affecting Brown Adipose Tissue Metabolism and Their Applications

Brown Adipose Tissue Energy Metabolism in Humans